Daratumumab, Bortezomib, and Dexamethasone for Multiple Myeloma.
N Engl J Med. 2016 Aug 25;375(8):754-66. doi: 10.1056/NEJMoa1606038.
N Engl J Med. 2016.
PMID: 27557302
Free article.
Clinical Trial.